Nicholas Buss
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- S100 Proteins and Annexins 3
- Genetics 5
- Virus-based gene therapy research 3
- Neurogenetic and Muscular Disorders Research 2
- Co-authors
- Lolke de Haan (3 shared papers)Jacintha Shenton (1 shared paper)Mary McFarlane (1 shared paper)Simon J. Henderson (1 shared paper)Felicity N. E. Gavins (3 shared papers)Julia C. Buckingham (2 shared papers)Olivier Danos (3 shared papers)Paul M. Holloway (1 shared paper)
- Journals
- Molecular Therapy — Methods & Clinical Development (3 papers)Current Opinion in Pharmacology (2 papers)Journal of Clinical Investigation (2 papers)Circulation (2 papers)The FASEB Journal (2 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Nicholas Buss
21 papers receiving 718 citations
Peers
Comparison fields: 5 of 92
- Virology 57
- Radiology, Nuclear Medicine and Imaging 219
- Ophthalmology 76
- Immunology 135
- Molecular Biology 402
Countries citing papers authored by Nicholas Buss
This map shows the geographic impact of Nicholas Buss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Buss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Buss more than expected).
Fields of papers citing papers by Nicholas Buss
This network shows the impact of papers produced by Nicholas Buss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Buss. The network helps show where Nicholas Buss may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicholas Buss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 315 | |
| 2 | 2019 | 109 | |
| 3 | 2012 | 63 | |
| 4 | 2022 | 46 | |
| 5 | 2002 | 33 | |
| 6 | 2005 | 26 | |
| 7 | 2008 | 26 | |
| 8 | 2005 | 26 | |
| 9 | 2021 | 22 | |
| 10 | 1999 | 16 | |
| 11 | 2015 | 16 | |
| 12 | 2018 | 14 | |
| 13 | 1997 | 8 | |
| 14 | 2023 | 5 | |
| 15 | 2018 | 3 | |
| 16 | 2020 | 2 | |
| 17 | Abstract 14664: Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of Recombinant Human Lecithin-Cholesterol Acyltransferase (MEDI6012) in Subjects With Stable Coronary Heart Disease | 2017 | 1 |
| 18 | 2025 | 1 | |
| 19 | 2011 | 1 | |
| 20 | 2021 | 1 |
About Nicholas Buss
Nicholas Buss is a scholar working on Molecular Biology, Genetics, Genetics, Virology and Radiology, Nuclear Medicine and Imaging, having authored 22 papers that have together received 735 indexed citations. Recurring topics across this work include HIV Research and Treatment (3 papers), Virus-based gene therapy research (3 papers), S100 Proteins and Annexins (3 papers), Neurogenetic and Muscular Disorders Research (2 papers), Cardiac Imaging and Diagnostics (2 papers), Lysosomal Storage Disorders Research (2 papers), Immune Response and Inflammation (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Virology (57 citations), Radiology, Nuclear Medicine and Imaging (219 citations), Ophthalmology (76 citations), Immunology (135 citations) and Molecular Biology (402 citations). Nicholas Buss has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Lolke de Haan, Jacintha Shenton, Mary McFarlane, Simon J. Henderson, Felicity N. E. Gavins, Julia C. Buckingham, Olivier Danos, Paul M. Holloway, Stephen J. Getting and Michele Fiscella. Their work appears in journals such as Molecular Therapy — Methods & Clinical Development, Current Opinion in Pharmacology, Journal of Clinical Investigation, Circulation and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.